Significant signal for Steven-Johnson syndrome in patients treated with atezolizumab

2021 ◽  
Vol 1883 (1) ◽  
pp. 12-12
Keyword(s):  
Johnson Syndrome ◽  
Steven Johnson Syndrome

scholarly journals Steven-Johnson syndrome may NOT be due to ayurvedic drugs - 1

2012 ◽  
Vol 44 (3) ◽  
pp. 427
Author(s):  
G Pallavi ◽  
KL Virupaksha Gupta
Keyword(s):  
Ayurvedic Drugs ◽  
Johnson Syndrome ◽  
Steven Johnson Syndrome

scholarly journals Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis

2016 ◽  
Vol 10 (1) ◽  
pp. 17-23 ◽  
Author(s):  
Ryota Niikura ◽  
Takako Serizawa ◽  
Atsuo Yamada ◽  
Shuntaro Yoshida ◽  
Mariko Tanaka ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumors ◽  
Imatinib Treatment ◽  
Efficacy And Safety ◽  
Tarry Stool ◽  
Dialysis Patients ◽  
Stromal Tumors ◽  
Duodenal Gist ◽  
Johnson Syndrome ◽  
Old Japanese ◽  
Steven Johnson Syndrome

The number of cancer patients undergoing dialysis has been increasing, and the number of these patients on chemotherapy is also increasing. Imatinib is an effective and safe therapy for KIT-positive gastrointestinal stromal tumors (GIST), but the efficacy and safety of imatinib in dialysis patients remain unclear. Because clinical trials have not been conducted in this population, more investigations are required. We report on a 75-year-old Japanese man undergoing dialysis who presented with massive tarry stool from a duodenal GIST. The duodenal GIST was 14 cm in diameter with multiple liver and bone metastases. The patient underwent an urgent pancreaticoduodenectomy to achieve hemostasis. After surgery, he was administered imatinib 400 mg/day. No severe adverse event including myelosuppression, congestive heart failure, liver functional impairment, intestinal pneumonia, or Steven-Johnson syndrome occurred, and the liver metastasis remained stable for 4 months. During chemotherapy, hemodialysis continued three times per week without adverse events. We suggest that regular-dose imatinib is an effective and safe treatment in patients with GIST undergoing dialysis. In addition, we present a literature review of the effectiveness and safety of imatinib treatment in dialysis patients.

scholarly journals Oral manifestations of herbal medicine induced Steven Johnson syndrome in 3 Nigerian paediatric patients: case report

2020 ◽  
Vol 4 ◽  
Author(s):  
Aderonke Omolola Oluwo ◽  
Folakemi Olutoyin Irewole-Ojo ◽  
Cecilia Abimbola Mabogunje
Keyword(s):  
Case Report ◽  
Herbal Medicine ◽  
Oral Manifestations ◽  
Paediatric Patients ◽  
Johnson Syndrome ◽  
Steven Johnson Syndrome

scholarly journals Toxic Epidermal Necrolysis and Steven–Johnson Syndrome: A Comprehensive Review

2020 ◽  
Vol 9 (7) ◽  
pp. 426-439 ◽  
Author(s):  
Olivia A. Charlton ◽  
Victoria Harris ◽  
Kevin Phan ◽  
Erin Mewton ◽  
Chris Jackson ◽  
...  
Keyword(s):  
Toxic Epidermal Necrolysis ◽  
Comprehensive Review ◽  
Johnson Syndrome ◽  
Steven Johnson Syndrome

scholarly journals Quetiapine- and Valproate-Associated Neutropenia and Thrombocytopenia After Lamotrigine-Induced Steven-Johnson Syndrome

2012 ◽  
Vol 32 (1) ◽  
pp. 133-134 ◽  
Author(s):  
Li-Ren Chang ◽  
Hung-Chieh Wu Chang ◽  
Yu-Hsuan Lin
Keyword(s):  
Johnson Syndrome ◽  
Steven Johnson Syndrome

Steven-Johnson Syndrome (SJS) in a Multiple Myeloma patient treated with lenalidomide and low dose dexamethasone regimen: a rare Case Report

2015 ◽  
Vol 3 (3) ◽  
pp. 353-355
Author(s):  
Dr Lohit kumar Kalita ◽  
◽  
Dr Chayanika Kalita ◽  
Dr Pabitra Kamar Gogoi ◽  
Dr Umesh Ch. Sarma ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Case Report ◽  
Rare Case ◽  
Low Dose ◽  
Myeloma Patient ◽  
Multiple Myeloma Patient ◽  
Johnson Syndrome ◽  
Rare Case Report ◽  
Steven Johnson Syndrome
Sign in / Sign up

Export Citation Format

Share Document